Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
SARS-CoV-2 감염에 대한 강력한 중화 항체는 몇 달 동안 지속됩니다.
Report
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Anti-spike
Antibody Response
Antibody titers
binding
caused
chance
Cohort
coronavirus
COVID-19
COVID-19 case
dataset
detectable
determine
global pandemic
humoral immune response
Immunoglobulin
Immunoglobulin G
individual
infected individual
infected individuals
Infection
Longevity
majority
Mild
mild to moderate
Mild-to-moderate
moderate
Moderate COVID-19
Mount Sinai
Mount Sinai Health System
neutralization
Neutralizing
neutralizing antibody
neutralizing antibody responses
Neutralizing antibody titer
neutralizing antibody titers
New York City
potency
Reinfection
remains uncertain
respiratory
robust
robustness
SARS-CoV-2
SARS-CoV-2 antibodies
SARS-CoV-2 antibody
SARS-COV-2 infection
SARS-CoV-2 spike protein
Science
screened
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
significantly
Spike protein
Symptom
System
the antibody response
the SARS-CoV-2
titers
Viral
viral spike protein
virus
[DOI] 10.1126/science.abd7728 PMC 바로가기 [Article Type] Report
[DOI] 10.1126/science.abd7728 PMC 바로가기 [Article Type] Report